SEC Form 4 · accession 0001127602-17-016753

AMGEN INC · AMGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, HR

Period of report

May 1, 2017

Accepted (ET)

May 3, 2017 · 8:51 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000318154

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2,F3	May 1, 2017	A	1,968	$0.00	A	15,322	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Nqso (Right to Buy)^F4	$162.60	May 1, 2017	A	17,429	A	May 1, 2019	May 1, 2027	Common Stock	17,429	17,429	D

F1The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.
F2These share include the following RSUs granted under the Company's equity plans: 4,795 RSUs which vest in one installment of 1,198 on 2/7/2018 and three equal installments of 1,199 on 2/7/2019, 2/7/2020 and 2/7/2021, respectively; and 1,968 RSUs which vest in two installments of 649 on each of 5/1/2019 and 5/1/2020 and one installment of 670 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3These shares include 31 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.